News
The latest treatments in NASH
As lifestyle changes and surgery are not always a viable option for treating NASH, new treatments are sorely needed. Looking to the near future, find out which drug therapies for NASH are currently in Phase III trials.
Recently, diabetes therapeutics called glitazones (pioglitazone in particular) have been the focus of several studies for NASH treatment and studies show that the use of glitazones can lead to improvements in steatosis, fibrosis and hepatocellular ballooning (damage to liver cells), but at the cost of significant weight gain1.
Current guidelines suggest that pioglitazone can be used for the treatment of steatohepatitis in patients with biopsy-proven NASH2.